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The Opioid Epidemic is a trending topic in the United States. Due to the skyrocketing 
numbers of deaths and overdoses of all races, society has stepped up and identified that there is 
a problem and something must be done. There is much research being conducted to determine 
what can be done to resolve what has been defined as a public health concern. Current research 
tends to be focused on how the drug is entering our country and the role that fentanyl plays in 
causing death and addiction. However, a somewhat overlooked issue is how individuals in the 
black community are treated differently and what results occur in relationship to these 
differences. As a disproportionately high number of Blacks die as a result of opioid addiction 
despite the lower addiction rates, it is important to consider what factors contribute to the higher 
number of Black deaths. In this study, I will consider how the disparate treatment of Blacks with 
opioid addiction by the medical community and the criminal justice system contribute to the 
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Opioids have been around dating back to BC. In the civil war, opioids were used to treat 
injured soldiers. Early in its use in the Civil War, doctors recognized a propensity for soldiers 
to form an addiction to opioids; at this early onset, opioid-based prescriptions became a rarer 
commodity as a result. Opioids are particularly successful in reducing pain. However, there are 
concerns about doctors overprescribing opioids, and patients abusing them. The types of abuse 
can consist of increased usage, a patient taking more than they are prescribed, or patients 
selling their pills to others. 
There are various drugs that fall under the category of Opioids; some that are 
frequently abused are listed and defined below: 
 Heroin- "is an opioid drug made from morphine, a natural substance taken from the 
seed pod of the various opium poppy plants. Heroin can be a white or brown powder, or 
a black sticky substance known as black tar heroin. Other common names for heroin 
include big H, horse, hell dust, and smack" (NIDA 2019). 
 Fentanyl- "is a powerful synthetic opioid that is similar to morphine but is 50 to 100 
times more potent. It is a prescription drug that is also made and used illegally" (NIDA 
2019). 
 Oxycodone- a prescription drug that is used to treat chronic pain. "These drugs act by 
attaching to opioid receptors in the brain and spinal cord, and blocking the transmission 
of pain messages to the brain" (NIDA 2019). 
 Vicodin- "a fixed-dose combination analgesic containing acetaminophen, or N-acetyl-p-








pain reliever prescribed by US oral surgeons after the extraction of third molars" (Moore 
et al. 2016). 
 Oxycontin – “A prescription used to manage severe pain. It has been used for cancer 
patients. There have been studies to indicate that this is the best medicine to prescribe 
for cancer patients and has reduced depression” (Di & Xu 2018). 
Significance of Study 
The recent opioid epidemic can be viewed differently in the black and white 
communities. Historically, various factors demonstrate a difference in how the black community 
is affected in comparison to the white community. One of the factors is the preconceived notion 
that if an individual is black, they can withstand more pain. So, they are less likely to obtain a 
prescription or recommendation for pain. Another misconception is that if a black was to 
receive a prescription for pain, they are more likely to sell the medication. These kinds of 
negative stereotypes play a part in blacks being criminalized following an arrest for their 
use/abuse of a substance versus being allowed the option of substance abuse treatment. If 
treatment for Blacks is to occur as a result of an arrest, it is highly likely that it will occur while 
incarcerated and not part of a recovery program outside of the justice system. Treatment while 
incarcerated can serve as a means to get out of prison more expeditiously. So, then the question 
arises, is an incarcerated individual seeking substance abuse treatment for help or to reduce his 
or her sentence? "It is no secret that African Americans have historically been incarcerated at far 
greater rates than whites for drug dealing and trafficking. Although African Americans and 
White Americans use illicit drugs at similar rates, the former are ten times more likely to be 
incarcerated for drug crimes; African Americans constitute roughly 12% of drug users, but 








concern that is being placed on the current trend of opioids versus the initial trend in 1979 to 
the mid-90's where blacks were the prominent face during that era. 
The rapid increase in overdoses and deaths are what has led society to reach the 
conclusion that the use of Opioids is becoming an epidemic. In its most common use, pain 
reduction is what Opioids are prescribed for. There are short term and long-term effects of 
Opioids. Some of the short-term effects consist of an uncontrollable itch, vomiting, and 
xerostomia (dry mouth). There are also long-term effects, such as insomnia, sweating, painful 
withdrawals, and death. Tolerance is usually built amongst individuals that use regularly, and an 
increase occurs in the amount of usage. After continued use, once an individual attempt to quit 
their drug use, they can experience withdrawals. This was often described in the treatment world 
years ago as "dope sick". Two common types of drugs used to curve the overdose effects are 
methadone and Naloxone. Methadone is in pill form, and Naloxone is similar to a nasal spray. 
Naloxone can be administered in two ways, injection or intranasal. Once administered, it 
reverses the effects of an opioid overdose. It works by rapidly binding to opioid receptors and 
blocking the effects of opioid drugs. 
According to the US Department of Health and Human Services, it was not until 2017 
that the US Government declared a public health emergency to address the opioid crisis. In 2015, 
52,404 Americans died from drug overdoses, and preliminary numbers indicate at least 64,000 
died in 2016 (HHS 2017). Combatting the opioid problem became a priority as a result of the 
recent statistics of numerous Americans losing their lives to this particular drug. Below there is 
a five-point strategy created by HHS to combat addiction. 
1. Access: Better Prevention, Treatment, and Recovery Services 








while making it easier for states to receive waivers to cover treatment through their Medicaid 
programs. (Issued five such SUD waivers since PHE declaration.) 
2. Data: Better Data on the Epidemic 
HHS is improving our understanding of the crisis by supporting the gathering of timely, 
specific public health data and reporting, including through accelerating CDC's reporting of drug 
overdose data. 
3. Pain: Better Pain Management 
HHS wants to ensure everything we do — payments, prescribing guidelines, and more — 
promotes healthy, evidence-based methods of pain management. 
4. Overdoses: Better Targeting of Overdose-Reversing Drugs 
HHS works to better target the availability of lifesaving overdose-reversing drugs. The 
President's 2019 Budget includes $74 million in new investments to support this goal. 
5. Research: Better Research on Pain and Addiction 
HHS supports cutting edge research on pain and addiction, including through a new NIH 
















In the article, Higher doses of Naloxone are needed in the synthetic opioid era the 
authors discussed a study completed on animals to determine the need and effects of the 
Naloxone (Moss & Carlo, 2019). It was initially concluded that based on the quantity and quality 
of Opioids that a person was ingesting, the amount of Naloxone provided was not being 
reversed. The amount of Naloxone administered was too low. It was found that more Naloxone 
was needed to effectively reverse the drug fentanyl because it is so powerful. This is sometimes a 
result of the additives of other drugs, which can consist of heroin, methamphetamines, cocaine, 
or MDMA. 
As the US experienced the rise of Opioid use, it was noted that from 2015 to 2016 that 
overdose and mortality rates in Baltimore increased by 249% from 120 to 419 (Park et al. 2018). 
This study focused on the non-fatal overdose of the Baltimore Syringe Services Program (SSP). 
This group consists of clients who primarily inject heroin. A non-experimental survey was used. 
The target population and sampling frame eligibility criteria included being a registered SSP 
client and being at least 18 years of age. The treatments and methods of collecting data consisted 
of a brief screening that took place with eligible clients taking a 30-minute interviewer-
administered computer-assisted personal interview survey. About half (54%) of participants were 
ages 45 and over, the majority (65%) were male, 52% were non-Hispanic black, 41% were non-
Hispanic white, and 62% had graduated from high school/GED (Park et al. 2018). 
In this study, significant factors were identified as playing a part in the mortality rate of 
individuals who injected various drugs. The availability of Naloxone and drug treatment played 








where less educational literature and help existed, the number of fatal overdoses was 
significantly higher. Many of the overdoses that occurred were related to the drug fentanyl. The 
high potency of this drug, unfortunately, is what kills and attracts users. As the users continue to 
look for the ultimate high in most cases are very close to death if not death. 
As a result of the rising numbers of drug overdoses in the US, some communities are 
taking a look at their own problems. Identifying Unreported Opioid Deaths Through Toxicology 
Data and Vital Records Linkage: Case Study in Marion County, Indiana, 2011-2016 an area that 
in "over a 6-year period, 57.7% of accidental overdose deaths were unspecified and 34.2% 
involved opioids. Toxicology data showed that 86.8% of unspecified cases tested positive for 
an opioid" (Lowder et al. 2018). The focus is the inaccuracy of coroner's reports, leading readers 
to conclude that many overdoses are reported but there is not always a specified drug associated 
with the overdose. 
This study of specific overdose cases and toxicology reports from the Marion County 
Coroner's Office (MCCO) in Marion County, Indiana proceeded to determine how many deaths 
were related to opioids. The toxicology reports were examined and broken down to look at the 
various drugs that could be found within Opioids. This allowed the examiners to see if there 
were derivatives of Opioids and, if so, what particular type. It was determined that the number 
of Opioid cases doubled over four years. 
I would have to agree with some of the discussion in this article about educating the 
necessary individuals involved with reporting deaths. It mainly goes back to the coroner and 
what is determined from toxicology reports. In the unspecified drug cases, there should be 
more done about such cases. I look at the other side of being a loved one who suddenly loses a 








the data if someone is trying to report on the amount of specified opioid cases. There is a 
known problem with Opioids in the US, but it is indeterminable if the issue existed before now 
and simply went unreported. It very well could have been; this is not the first we have heard of 
significant numbers of Heroin overdoses. Also, think of the many deaths where an autopsy was 
never completed. For some populations, such as our homeless populations and poor 
communities, the numbers of autopsies are few. 
Medical Management of Opioids 
Opioid use and manufacturing are currently managed more carefully. Due to opioids 
being a pain reliever, the drug is given to relieve chronic pain and long-term illnesses. There are 
situations in which the prescribed medication is abused by the patient who does not take the 
medication regularly as prescribed. There are also circumstances where prescribed medications 
are sold to opioid users. "Physicians' prescriptions became the major source of opioid abuse 
over the past two decades, as prescription opioid sales rose 300%, with more than 50% 
designated for chronic noncancer pain. This shift in practice norms created a risk for diversion, 
use disorder, and overdose deaths. This change was fueled by the acceptance of low-quality 
evidence that opioids are an effective, relatively benign remedy for managing chronic pain" 
(Madras, 2017, p.441). 
Treatment for Opioid addiction can consist of various levels of care, depending on the 
severity of the addiction. A person's eligibility for treatment services can be determined during 
the intake process. At intake, an individual is given an assessment and interviewed to learn 
what level of care is deemed appropriate. This process can take anywhere from two to three 
hours. Families can be involved in this portion of the intake process. There is a time during the 








drug history. Based on my past experiences as a substance abuse counselor, when family 
members are involved in recovery, patients have better support and the best chance for lasting 
recovery. After the intake, it is then determined what level of care the client meets at the time of 
service. 
In accordance to American Society of Addiction Medicine (ASAM) criteria the first level 
of care is outpatient; this allows a substance user to come into a treatment setting for sessions to 
gain insight about addiction with other addicts. The sessions can vary based on how many days 
and hours are recommended. The next level of care is Level Two, Intensive Outpatient. At this 
level, the days and hours of treatment sessions may increase with some partial hospitalization. 
Level three is residential inpatient care, which allows the person to be away from the 
environment that contributed to use. Patients are usually amongst others going through the same 
type of treatment. At this level, patients can have visits with staff approval. Arrangements are 
often made for family therapy or sessions at this time, depending on the facility. The final level 
of care is Intensive Residential, which consists of detox or medical management of some sort. 
This allows the person to withdraw from their drug of choice in a safe environment while being 
monitored by staff. 
Each level of care is individualized based on a treatment plan designed with objectives 
and goals to accomplish. The personalized treatment plans integrate an individual's substance 
abuse and mental health problems as well as lifestyle and daily commitments. These 
treatment plans are followed during the stay of the client and reviewed to note progress or 
regress in an individual's treatment. Once the goals are met this allows an individual to move 
down a level in treatment. The cost of drug treatment often poses a problem for those who 








been used for opioid agonist therapy (OAT) (Saloner, Stoller, and Barry 2016). There are 
sliding fee skills that often can determine the cost of treatment. Some insurances limit the 
amount of service that are covered in a year. It is up to the treatment agency to call and report 
treatment sessions as directed by the insurance company. 
The observation that Canada and the United States have the highest per capita opioid 
analgesic consumption is central to the belief that these medicines are overprescribed, leading to 
the unrealistic expectation that curtailing dispensing will automatically reduce overdose. In 
practice, overprescribing is an amalgamation of prescribing behaviors encompassing starting 
dose, number of units in a prescription, dosing schedules, potency, and other factors (Dagupusta 
et al. 2018). 
It was not until within the last few years that a strong presence has hovered around the 
need for curing this epidemic. One of the suggested antagonists used to reverse the opioid 
overdose is Narcan (Naloxone). Narcan is administered like a nose spray. It is simply put in the 
addict's nose and released. Although the use of Narcan is the start to assist with this problem, it 
definitely is not the definitive answer. It is saving lives, but many continue to lose this battle. 
One of the current Opioids that appear to be affecting individuals is fentanyl. Fentanyl is a 
synthetic opioid and is prescribed for severe pain. The medication can ultimately be deadly 
depending on the amount and form of administering. This drug can be prepared in various ways 
to attract a user. It is the various additives that dealers add to their supply to make the demand 
high. People continue to abuse this drug that can ultimately lead to death. As a result of this 
increased drug abuse and deaths, the US began to focus on ways to combat this opioid 
epidemic. 








In this particular section, I decided to focus on a close friend, who experienced 22 years of 
addiction, 24 years of county jail/prison, and 32 years of sobriety. He currently has a MSW, 
CADC, and owns his business, which is the success of his journey. It was not a journey that he 
thought would end so successfully. At a young age, drugs became a first love for a young man 
growing up in Chicago. His drug of choice ultimately became heroin using daily intravenously. 
This drug took over the daily lifestyle and ultimately his life. He no longer had a joy for anything 
in life but heroin. He would do what he could to obtain it, and eventually, this addiction led to 
incarceration. It was not until this prison sentence that he began to realize the life he had chosen 
to live as a result of drugs. It was in prison that he obtained some accomplishments -- a 
certificate of culinary arts, a certificate in building maintenance, an EMT certificate, a GED, and 
an Associate's Degree. By receiving such accolades, he began to make himself and loved ones 
proud again. 
The accolades only continued after completing twenty-four years incarcerated. He went 
on to receive a Bachelor's degree and a Master's Degree in social work. He landed jobs in 
treatment settings encouraging youth especially not to go down the path he chose and that it was 
not too late to turn their lives around. He became a (CADC) certified alcohol and drug counselor. 
In the meantime, he did work on the side by selling items to the community. Initially, he began 
by selling CDs and t-shirts. He went on to complete a program through the incubator to gain 
insight on owning his own business. The opportunity landed him the chance to open his own 
store which remains open to this day and his supply of items has manifested to much more. He 
still is often reminded that he is in recovery, and as the 12-step saying goes "1 day at a time". He 
has been invited back into treatment settings to share his story and knowledge of recovery. 






































Are we headed towards change with this Opioid epidemic? Yes, but there is much more 
that can be researched. It is a step towards change when a problem has been acknowledged. As 
we know, history repeats itself. Although there should be better and effective ways to combat 
this epidemic before it gets any worse, it is hard to say if society has a better grip on diminishing 
this problem because the numbers were so large to begin with. It is safe to say that some of the 
treatment methods are being implemented and are working. There are programs like MAT 
Medication-Assisted Treatment that are proving to be effective with incarcerated individuals. 
According to (Bone et al. 2018) the absence of MAT in prisons and jails results in poor outcomes 
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